SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000812796-09-000054
Filing Date
2009-05-15
Accepted
2009-05-15 15:13:49
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 DOR 10Q FOR 1Q 2009 dor10q01q-2009.htm 10-Q 737953
2 CEO CERT 1Q 2009 certceo.htm EX-31.1 12717
3 CFO CERT 1Q 2009 certcfo.htm EX-31.2 12324
4 CEO 906 SOX 1Q 2009 ceo906sox.htm EX-32.1 7265
5 CFO 906 SOX 1Q 2009 cfo906sox.htm EX-32.2 5912
  Complete submission text file 0000812796-09-000054.txt   777781
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 09832328
SIC: 2834 Pharmaceutical Preparations